NBIX - Neurocrine Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$195.29
DETAILS
HIGH:
$230.00
LOW:
$160.00
MEDIAN:
$195.00
CONSENSUS:
$195.29
UPSIDE:
12.17%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 360,136 | $47.4M | 0.1% | +191,564 | INCREASED |
| Dalio | 148,141 | $19.5M | 0.1% | -1,849 | DECREASED |
| Cooperman | 89,184 | $11.7M | 0.0% | +89,184 | NEW |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-10 | Delaet Ingrid | officer: Chief Regulatory Officer | M-Exempt | 4,367 | $106.02 | $463K |
| 2026-07-10 | Delaet Ingrid | officer: Chief Regulatory Officer | SELL | 4,367 | $181.02 | $791K |
| 2026-07-09 | Lippoldt Darin | officer: Chief Legal Officer | SELL | 10,000 | $179.60 | $1.8M |
| 2026-07-09 | Lippoldt Darin | officer: Chief Legal Officer | M-Exempt | 10,000 | $81.49 | $815K |
| 2026-07-09 | Delaet Ingrid | officer: Chief Regulatory Officer | SELL | 8,433 | $178.72 | $1.5M |
| 2026-07-08 | Delaet Ingrid | officer: Chief Regulatory Officer | SELL | 2,737 | $178.54 | $489K |
| 2026-07-08 | Delaet Ingrid | officer: Chief Regulatory Officer | M-Exempt | 2,737 | $103.52 | $283K |
| 2026-07-09 | Delaet Ingrid | officer: Chief Regulatory Officer | M-Exempt | 8,433 | $103.52 | $873K |
| 2026-07-07 | Delaet Ingrid | officer: Chief Regulatory Officer | M-Exempt | 3,401 | $103.52 | $352K |
| 2026-07-07 | Delaet Ingrid | officer: Chief Regulatory Officer | SELL | 3,401 | $178.57 | $607K |
| 2026-06-26 | Lippoldt Darin | officer: Chief Legal Officer | M-Exempt | 200 | $81.49 | $16K |
| 2026-06-29 | Lippoldt Darin | officer: Chief Legal Officer | SELL | 8,110 | $170.03 | $1.4M |
| 2026-06-26 | Lippoldt Darin | officer: Chief Legal Officer | SELL | 200 | $169.56 | $34K |
| 2026-06-29 | Lippoldt Darin | officer: Chief Legal Officer | SELL | 1,690 | $170.81 | $289K |
| 2026-06-29 | Lippoldt Darin | officer: Chief Legal Officer | M-Exempt | 8,110 | $81.49 | $661K |
| 2026-06-29 | Lippoldt Darin | officer: Chief Legal Officer | M-Exempt | 1,690 | $81.49 | $138K |
| 2026-06-05 | SHERWIN STEPHEN A | director | SELL | 7,883 | $163.81 | $1.3M |
| 2026-06-05 | SHERWIN STEPHEN A | director | M-Exempt | 15,000 | $53.64 | $805K |
| 2026-06-05 | SHERWIN STEPHEN A | director | SELL | 2,549 | $164.44 | $419K |
| 2026-06-05 | SHERWIN STEPHEN A | director | SELL | 6,896 | $165.79 | $1.1M |
| 2026-06-05 | SHERWIN STEPHEN A | director | M-Exempt | 10,000 | $79.79 | $798K |
| 2026-06-05 | SHERWIN STEPHEN A | director | SELL | 5,829 | $166.56 | $971K |
| 2026-06-05 | SHERWIN STEPHEN A | director | SELL | 1,843 | $167.31 | $308K |
| 2026-06-05 | Onyia Jude | officer: Chief Scientific Officer | G-Gift | 2,441 | -- | -- |
| 2026-06-04 | Norwalk Leslie V | director | SELL | 1,250 | $168.06 | $210K |